More on TCRT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (11/17/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alaunos Therapeutics (NQ:TCRT)
Delayed: 2.15 -0.07 (3.15%)
Prev. Close $2.22  
Open$2.21 
52 Wk High$ 
52 Wk Low$ 
Day High$2.23 
Day Low$2.15 
P/E N/A  
EPS$ 
Volume16,128 

Friends, Peers and Foes (?): ELAB (more...)

Jun 17, 2026 04:48 PM Form 4 Alaunos Therapeutics, For: Jun 17 Filed by: Weis Holger
May 27, 2026 04:33 PM Form 4 Alaunos Therapeutics, For: May 22 Filed by: Weis Holger
May 26, 2026 11:02 AM Alaunos reports obesity drug shows weight loss in mouse studies
May 26, 2026 11:01 AM Form 8-K Alaunos Therapeutics, For: May 26
May 26, 2026 11:01 AM Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
May 18, 2026 08:02 AM Alaunos reports preclinical data for metabolic drug candidate ALN1003
May 18, 2026 08:01 AM Form 8-K Alaunos Therapeutics, For: May 18
May 18, 2026 08:00 AM Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
May 15, 2026 05:30 PM Form 10-Q Alaunos Therapeutics, For: Mar 31
May 4, 2026 04:05 PM Valion Bio Appoints Melinda Lackey as General Counsel
View All Articles

Entities mentioned with TCRT

View All Entities